Memorial Day! 45% Off Premium Subscription Claim Offer ⏰ 0d 00h 00m 00s

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 4.084 23 days ( -24.62 % )
Last Price $6.58 2.02 %
High/ Low $6.21 - $6.84 23.99%
Chg 7 Days 13.64 % $5.79 $6.58
Chg 30 Days 24.62 % $5.28 $6.58
Chg 12 mos 53.38 % $4.29 $6.58
Trend - 3 mos 14.94 % Width: 53.82 %
Trend - 12 mos 11.20 % Width: 68.13 %
Pred. range - 3 mos $5.30 - $8.15 -19.45 % - 23.90 %
Pred. range - 12 mos $4.74 - $7.97 -27.94 % - 21.16 %
Short MA avg 3 mos Sell May 05, 2025 - 14 days
Long MA avg 3 mos Buy Apr 21, 2025 - 24 days
Short/Long MA avg 3 mos Buy Apr 22, 2025 - 23 days
Short MA avg 12 mos Sell May 13, 2025 - 8 days
Long MA avg 12 mos Sell May 06, 2025 - 13 days
Short/Long MA avg 12 mos Buy May 09, 2025 - 10 days
Pivot Short Sell May 07, 2025 - 12 days
Bollinger Buy Apr 04, 2025 - 34 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT ABEONA THERAPEUTICS INC.
Abeona Therapeutics.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;...
GOLDEN STAR
Ticker Change Signal Date
UAA
$5.84
11.64% May 09
IIPR
$54.61
1.70% May 09
HBM
$7.41
14.44% May 05
PODD
$257.01
24.90% May 02
GT
$9.14
21.77% Mar 21

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE